As per the International Diabetes Foundation, the number of adults suffering from diabetes was around 425 million and is expected to reach 630 million by 2045. The prevalence of diabetes is primarily increasing owing to the rapid adoption of sedentary lifestyle and unhealthy food habits. This further shows that the demand for blood glucose monitoring systems will increase, thereby driving the global blood glucose monitoring systems market. As per the report, the global market was valued at USD 10.09 Billion in the year 2018 and is projected to be worth USD 17.06 Billion by 2026. In addition to this, the global market is expected to exhibit a CAGR of 6.7% during the forecast period.
Highlights of the Report:
· In-depth analysis of various insights, namely, Blood Glucose Monitoring Systems Market trends, growth drivers, opportunities, and other related challenges.
· Comprehensive details of key market players, their core competencies, and Blood Glucose Monitoring Systems Market share.
· The potency of suppliers and buyers to make better business decisions.
· Lists out the market size in terms of volume.
For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/blood-glucose-monitoring-market-100648
Key Players Operating in The Blood Glucose Monitoring Systems Market Include:
Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:
· F. Hoffmann-La Roche Ltd.
· Abbott
· Ascensia Diabetes Care Holdings AG
· Dexcom, Inc.
· Medtronic
· B. Braun Melsungen AG
· Lifescan Inc.
· Terumo Medical Corporation
· DiamonTech GmbH
Detailed Table of Content:
. Introduction
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
4. Key Insights
4.1 Prevalence of Diabetes, By Key Countries/ Key Regions, 2018
4.2 Pricing Analysis, By Key Regions/ Key Market Players
4.3 New Product Launches, By Key Market Players
4.4 Detailed Product Mapping, By Key Market Players
4.4 Recent Industry Developments Such As Mergers & Acquisitions
5. Global Blood Glucose Monitoring Systems Market Analysis, Insights and Forecast, 2015-2026
5.1. Key Findings / Summary
5.2. Market Analysis, Insights and Forecast – By Device
5.2.1 Continuous Glucose Monitoring Systems (CGM)
5.2.2 Self-Monitoring Blood Glucose (SMBG) Systems
5.3. Market Analysis, Insights and Forecast – By Type
5.3.1 Invasive
5.3.2 Non-Invasive
5.4 Market Analysis, Insights and Forecast – By Modality
5.4.1 Wearable
5.4.2 Non- Wearable
5.5. Market Analysis, Insights and Forecast – By Distribution Channel
5.5.1 Institutional Sales
5.5.2 Retail Sales
5.6. Market Analysis, Insights and Forecast – By Region
5.6.1 North America
5.6.2 Europe
5.6.3 Asia Pacific
5.6.4 Latin America
5.6.5 Middle East & Africa
6. North America Blood Glucose Monitoring Systems Market Analysis, Insights and Forecast, 2015-2026
6.1. Key Findings / Summary
6.2. Market Analysis, Insights and Forecast – By Device
6.2.1 Continuous Glucose Monitoring Systems (CGM)
6.2.2 Self-Monitoring Blood Glucose (SMBG) Systems
6.3. Market Analysis, Insights and Forecast – By Type
6.3.1 Invasive
6.3.2 Non-Invasive
6.4. Market Analysis, Insights and Forecast – By Modality
6.4.1 Wearable
6.4.2 Non- Wearable
6.5. Market Analysis, Insights and Forecast – By Distribution Channel
6.5.1 Institutional Sales
6.5.2 Retail Sales
6.6. Market Analysis, Insights and Forecast – By Country
6.6.1 U.S.
6.6.2 Canada
